We finally have a vaccine, but will this bring about a return to normality?
With unprecedented speed, the UK has become the first country to approve emergency use authorization for a COVID-19 vaccine that has been tested in a large-scale clinical trial.1 While this is a welcome milestone, it is important to remember that, as the vaccine is rolled out to millions of people, scientists and the public still […]View
Ensuring an open channel with regulatory and medical policy opinion leaders during COVID-19
Many companies, particularly new entrants into the U.S. pharma arena, are facing some level of disruption or impact on their projected timelines for seeking FDA licensure, gathering data from trials for filing, conducting health economics analyses needed to demonstrate improved outcomes, or conducting real-world evidence studies that can help inform medical societies’ deliberations on clinical […]View
Assessing and managing issues around clinical trials: a multi-stakeholder approach
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.View
COVID-19 brings real-world evidence center stage
Now, as we adjust to the era of COVID-19, RWE, and thus real-world research (RWR), has been pushed center stage, and industry, and the medical community as a whole, are turning to this research area for answers.View
The role of real-world evidence in the covid-19 era
Real-world evidence (RWE) can be used across development cycle to highlight unmet need, define priority patient segments, competitively position a product before launch, understand real-world treament patterns and outcomes, and to build an evidence base when clinical trial programs are delayed.Download PDF
Unlocking virtual medical congresses
Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.View
No two virtual congresses are the same
Each congress has a different structure to its overall program and method in delivering its scientific information, despite stating that they all plan to keep to the traditional congress format.Download PDF
Get in Touch
We know there are numerous considerations when it comes to the impact of COVID-19 and what this means for your organization. We are here to help.